IOT Enabled Bilirubin Level Monitoring and Controlling Using Photo Therapy

The innovative approach to neonatal jaundice treatment via an IoT -integrated system represents an important step forward in neonatal healthcare. The system ensures timely and efficient therapy by continuously monitoring the levels of bilirubin and administering photo-therapy, reducing the necessity for frequent blood tests. The non-intrusive monitoring device measures bilirubin concentrations using photo-metric techniques, with data transmitted to a central control unit for real-time processing. Advanced algorithms automatically adjust photo therapy parameters based on the severity of the j aundice. Using LEDs with optimal light spectra reduces the risk of skin damage during photo-therapy. Importantly, the system enables remote monitoring and control via an encrypted web or mobile interface, facilitating caregivers and healthcare professionals to make real-time decisions. This IoT -enabled solution has the potential to reduce testing frequency, provide precise treatment, and improve patient safety. This innovative IoT -enabled system for monitoring bilirubin levels and administering phototherapy offers several advantages, including reduced blood testing, precise and individualized treatment, and improved patient safety. It has the potential to transform Neonatal jaundice management, ensuring that affected infants receive timely and effective care while alleviating the strain on health care resources.